Orthocell LtdASX: OCC

CelGro Facilitates Lymphatic Vessel Regeneration Updated

· Issued by Orthocell Ltd

Filed with ASX · · 3 pages · English

Perth, Australia; 02 August 2021: Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell”, or the “Company”) advises that the announcement made today has been amended with an updated link to the publication and inclusion of the footnote. There has been no other changes to the announcement, a copy which is attached. Release authorised by Paul Anderson, Managing Director, Orthocell Ltd

Orthocell Ltd on 6ix

Earlier from Orthocell

Later from Orthocell

All Orthocell news releases